The deal range was $9.25-$9.40. Goldman Sachs and Leerink acted as joint book running managers for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNTA:
- Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares
- Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
- Centessa Pharmaceuticals Advances Narcolepsy Drug Trials
- Centessa announces open IND for ORX750
- Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024